Skip to content

Using light therapy to help treat Sickle Cell Anemia

Photobiomodulation Terapy: a novel approach to support the treatment of Sickle Cell Anemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-485qvzm
Enrollment
Unknown
Registered
2025-02-08
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle-cell anaemia with crisis

Interventions

Single-blind, randomized controlled study with individuals diagnosed with sickle cell anemia, over 12 years of age and weighing more than 40 kg. They will be randomly divided into control and treatmen
1800 seconds
total energy: 180 J), applied to both adults and adolescents. Patient response will be evaluated through routine blood analysis in the ward, with arterial and venous blood collection. The individual w
E02.594.540

Sponsors

Universidade Brasil
Lead Sponsor
Universidade Brasil
Collaborator

Eligibility

Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: Have a diagnosis of sickle cell anemia; be 12 years old; both sexes; the weight of these individuals must be equal to or greater than 40 kg; must be treated at the Hospital Foundation of Hematology and Hemotherapy of Amazonas

Exclusion criteria

Exclusion criteria: Individuals with a diagnosis of coagulation factor disorders; frequent and recent hemorrhagic episodes; glaucoma; pregnancy; the presence of malignant tumors or benign tumors with the potential to become malignant; active sepsis; chest trauma; history of tracheostomy; autoimmune disease; conditions of light sensitivity or use of photosensitive drugs; neurodegenerative diseases, and terminal illnesses will not be admitted to the study

Design outcomes

Primary

MeasureTime frame
Patients are expected to have pain reduction of at least 2 points. ;Increase oxygenation of patients with sickle cell anemia in crisis

Secondary

MeasureTime frame
Reduce the hospitalization time, in days, of patients with vaso-occlusive crises

Countries

Brazil

Contacts

Public ContactCarla Tim

Universidade Brasil

carla.tim@ub.edu.br+55-11-48589224

Outcome results

None listed

Source: REBEC (via WHO ICTRP)